Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Aakash Thakral

Physical Medicine & Rehabilitation Greeley, CO Medical Doctor

NPI 1831544816 CMS profile 7228534

6810 10Th St Ste 1167, Greeley, CO 80634

Open in the dashboard

General payments

$14,154

190 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Aakash Thakral of Greeley, CO is reported in the CMS Open Payments database as having received $14,154 across 190 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Physical Medicine & Rehabilitation profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,274 33
2024 General $3,826 63
2023 General $6,013 75
2022 General $1,741 14
2021 General $173 4
2019 General $127 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Aakash Thakral
  • Physical Medicine & Rehabilitation median
  • Middle half of Physical Medicine & Rehabilitation
  • National median

In program year 2025, general payments to Aakash Thakral were reported at $2,274. Among 4,146 Physical Medicine & Rehabilitation profiles paid that year, the median was $139 and the middle half received between $48 and $410.

Show as a table
Year Aakash Thakral Physical Medicine & Rehabilitation median Middle half National median
2019 $127 $133 $45–$390 $163
2020 $0 $88 $29–$272 $114
2021 $173 $116 $33–$360 $132
2022 $1,741 $123 $40–$378 $149
2023 $6,013 $131 $43–$396 $160
2024 $3,826 $141 $45–$409 $164
2025 $2,274 $139 $48–$410 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $6,047 62 payments
  2. Medtronic, Inc. $2,715 52 payments
  3. Abbott Laboratories $1,566 18 payments
  4. Nalu Medical, Inc. $1,090 10 payments
  5. MML US, Inc. $641 10 payments
  6. Nevro Corp. $603 10 payments
  7. Stryker Corporation $420 6 payments
  8. BIOTRONIK NRO, Inc. $234 3 payments
  9. SPR Therapeutics, Inc $221 4 payments
  10. Relievant Medsystems, Inc. $214 2 payments
  11. Other $403 13 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $11,210 178 payments
  2. Travel and Lodging $2,944 12 payments
Products named General payments · program years 2019–2025
  1. INTELLIS ADAPTIVESTIM $2,243 40 payments
  2. WaveWriter Alpha Prime 16 $1,481 31 payments
  3. Nalu Neurostimulation System $1,090 10 payments
  4. ReActiv8 $641 10 payments
  5. PROCLAIM Neuromodulation $541 6 payments
  6. Senza $453 8 payments
  7. PROCLAIM Neuromodulation $405 7 payments
  8. Infinion 16 $386 3 payments
  9. Intracept $312 3 payments
  10. ETERNA $269 2 payments
  11. Other $3,399 58 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 13 drugs

Part D claims

463

Median for Physical Medicine and Rehabilitation: 276

Drug cost

$7,810

Median for Physical Medicine and Rehabilitation: $5,921

Branded share of claims

10.6%

Median for Physical Medicine and Rehabilitation: 11.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Pregabalin Generic 79 $1,971
Lidocaine Generic 16 $1,218
Tizanidine Hcl Generic 64 $1,037
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 32 $694
Gabapentin Generic 53 $687
Baclofen Generic 20 $625
Duloxetine Hcl Generic 21 $376
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 17 $332
Oxycodone Hcl Generic 17 $244
Meloxicam Generic 74 $217

The 10 drugs with the highest cost, of 13 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 7,591 Part D prescribers listed as Physical Medicine and Rehabilitation; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 38 billing codes

Paid by Medicare

$198,451

Medicare's payments for the services billed

Medicare patients

274

Average age 74

Services billed

1,173

164 women, 110 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 66%
Ischemic heart disease 26%
Depression 26%
Osteoporosis 23%
Diabetes 22%
Chronic kidney disease 16%
COPD 14%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

190 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physical Medicine & Rehabilitation in Colorado

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record